Enhanced Antitumor Immune Response in 2'-5' Oligoadenylate Synthetase-Like 1- (OASL1-) Deficient Mice upon Cisplatin Chemotherapy and Radiotherapy. - Sim CK; Lee JH; Baek IJ; Lee SW; Lee MS (Journal of immunology research, 2019)